BiOmarkers in Urine, anTihypeRtensive trEAtment and blood pressure Control in Hypertensive patients - OUTREACH Study

The University of Manchester0 个研究点目标入组 240 人开始时间: 2017年12月7日最近更新: 2023年1月9日

适应症

试验速览

暂无简介。

•1. Male or female aged 18 years or above (min age 18 years old; no maximum age)
•2. Patients previously diagnosed with and pharmacologically managed for hypertension
•3. Patients with antihypertensive treatment with at least two antihypertensive medications
•4. Patients willing and able to give informed consent for study inclusion including all study assessments

•Current exclusion criteria as of 07/12/2022:
•1. Recent history of admission to hospital relating to their hypertension or treatment with antihypertensive medications (< 2 weeks of baseline visit, including admission to A&E)
•2. Refusal for 7-day home-based blood pressure monitoring
•3. Self-reported pregnancy or breastfeeding
•4. Female patients planning to conceive within the next 6 months
•Previous exclusion criteria from 11/03/2021 to 07/12/2022:
•1. Recent history of admission to hospital relating to their hypertension or treatment with antihypertensive medications (< 2 weeks of baseline visit, including admission to A&E)
•2. Refusal for 7-day home-based blood pressure monitoring
•3. Self-reported pregnancy or breastfeeding
•4. Female patients planning to conceive within the next 12 months
•Original exclusion criteria:
•1. Recent history of admission to the hospital (<2 weeks of baseline visit, including admission to A&E)
•2. Recent change in the prescribed antihypertensive medications (<2 weeks of baseline visit). Changes in antihypertensive drug dose are not considered an exclusion criterion if this is the only change within 2 weeks of the baseline visit
•3. Refusal for 7-day home-based blood pressure monitoring
•4. Self-reported pregnancy or breastfeeding
•5. Female patients planning to conceive within the next 12 months

发起方